Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis

Journal of the American Academy of Dermatology

Volumn 63, Issue 3, 2010, Pages

  Kwakkel Van Erp, Johanna M ^a   Haeck, Inge M ^a   Paantjens, Annelieke W M ^a   Van De Graaf, Ed A ^a   Van Ginkel, Walter G J ^a   Knol, Mirjam J ^a   De Bruin Weller, Marjolein S ^a   Lammers, Jan Willem J ^a   Knol, Edward F ^a   Bruijnzeel Koomen, Carla ^a   Otten, Henny G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD30 ANTIGEN; CYCLOSPORIN; MYCOPHENOLIC ACID; THYMUS AND ACTIVATION REGULATED CHEMOKINE; ENTERIC COATED TABLET;

ATOPIC DERMATITIS; CORRELATION COEFFICIENT; DISEASE SEVERITY; ENTERIC COATED TABLET; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LETTER; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZATION; BLOOD; COMPARATIVE STUDY; CONTROLLED STUDY; DERMATITIS, ATOPIC; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; MALE; OBSERVER VARIATION; PILOT STUDY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

ANTIGENS, CD30; BIOLOGICAL MARKERS; CHEMOKINE CCL17; CYCLOSPORINE; DERMATITIS, ATOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MYCOPHENOLIC ACID; OBSERVER VARIATION; PILOT PROJECTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TABLETS, ENTERIC-COATED; TREATMENT OUTCOME;

EID: 77955858695     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.02.015     Document Type: Article

References (5)

1. B. Kunz, A.P. Oranje, L. Labreze, J.F. Stalder, J. Ring, and A. Taieb Clinical validation and guidelines for the SCORAD index: consensus report of the European task force on atopic dermatitis Dermatology 195 1997 10 19
2. V. Bottari, A. Frezzolini, M. Ruffelli, P. Puddu, L. Fontana, and O. De Pita Cyclosporine A (CyA) reduces sCD30 serum levels in atopic dermatitis: a possible new immune intervention Allergy 54 1999 507 510
3. D. Hijnen, M. De Bruin-Weller, B. Oosting, C. Lebre, E. De Jong, and C. Bruijnzeel-Koomen Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis J Allergy Clin Immunol 113 2004 334 340
4. A.W. Paantjens, J.M. Kwakkel-van Erp, W.G. van Ginkel, D.A. van Kessel, J.M. van den Bosch, and E.A. van de Graaf Serum thymus and activation regulated chemokine levels post-lung transplantation as a predictor for the bronchiolitis obliterans syndrome Clin Exp Immunol 154 2008 202 208
5. A.M. Bauwens, E.A. van de Graaf, W.G.J. van Ginkel, D.A. van Kessel, and H.G. Otten Pre-transplant soluble CD30 is associated with bronchiolitis obliterans syndrome after lung transplantation J Heart Lung Transplant 25 2006 416 419